56
1 FDA OR USFDA BY HEMANG PATEL YOGESH PATEL JAIMIN PATEL TEJAS GOSWAMI ICRI- AHMEDABAD MSc. CT & CR (2011-13)

Usfda

Embed Size (px)

DESCRIPTION

this presentation will help to understand organization and function of USFDA.

Citation preview

Page 1: Usfda

1

FDA OR

USFDABY

HEMANG PATELYOGESH PATELJAIMIN PATEL

TEJAS GOSWAMIICRI- AHMEDABAD MSc. CT & CR (2011-13)

Page 2: Usfda

2

۩ Scientific, Regulatory, Public Health Agency

۩ Mission is to protect and promote public health.http://www.fda.gov/

Authority to regulate medical devicesFederal FD&C Act

Established regulatory controls for medical devices (May 28, 1976)

21 CFR Parts 800-1299.

The U.S. Food and Drug Administration is

Page 3: Usfda

3

Clinical chemistry and clinical toxicology

Hematology and pathology Immunology and

microbiology Anesthesiology Cardiovascular Dental Ear, nose and throat Gastroenterology & urology

devices

General and plastic surgery General hospital and

personal use Neurological Ophthalmic Orthopedic and physical

medicine Obstetrical and

gynecological Radiology

Medical Device Definition in Sec 201(h) of the FD&C Act

16 Classification Regulations21 CFR (part 800-1299)

Page 4: Usfda

4

Goal: Implement the National Commission’s recommendations

1981: 21 CFR Part 50 (Informed Consent Regulations)1981: 21 CFR Part 56 (IRB Regulations)

◦Subpart A: General provisions◦Subpart B: Organization and Personnel◦Subpart C: IRB Function and Operations◦Subpart D: Records and Reports◦Subpart E: Administrative Actions for Noncompliance

2001: 21 CFR Part 50, Subpart D – Additional Safeguards for Children in Clinical Investigations

FDA Regulations

Page 5: Usfda

5

۩ The Food and Drug Administration (FDA), established in 1930 as a part of the US Department of

Health and Human Services (DHHS), regulates products accounting for roughly 25% of the United

States gross national product.

INTRODUCTION : HISTORY OF THE FDA

Page 6: Usfda

6

۩ Virus-Toxin Law of 1902 (also referred to as the Biologics Control Act)

۩ Food and Drug Act of 1906

۩ Federal Food, Drug and Cosmetic Act [FD&C Act] of 1938:

۩ Durham-Humphrey Amendment of 1951:

۩ Kefauver-Harris Amendment of 1962:

۩ Medical Device Amendments of 1976:

۩ Anti-Tampering Regulations (1982):

Page 7: Usfda

7

۩ The U.S. Food and Drug Administration (FDA) is an agency of the US Department of Health and Human Services (DHHS) that is responsible for the safety regulation of:

◦ most types of foods ◦ drugs◦ vaccines◦ blood products◦ medical devices

What is FDA?

◦ dietary supplements◦ biological medical products◦ radiation-emitting devices ◦ veterinary products◦ cosmetics

Page 8: Usfda

8

۩ The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs.

۩ These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction.

Page 10: Usfda

10

Center for Veterinary Devices

Food and Drug Administration

Center for Biologics Evaluation and Research

Center for Devices and Radiological Health

National Center for Toxicological Research

Center for Food Safety and Applied Nutrition

Center for Drug Evaluation and Research

Office of Combination

Products

FDA Structure / Organization

Page 11: Usfda

11

Responsibility of FDA organization

Page 12: Usfda

12

Office of Device Evaluation

Office of In-Vitro Diagnostic

Devices & Safety

Office of Health & Industry Programs

Office of Science & Technology

Office of Compliance

Office of Surveillance & Biometrics

Center for Devices and

Radiological Health

CDRH Offices

Page 13: Usfda

13

Commissioner Center for Food Safety and Applied

Nutrition (CFSAN)

Center for Drug Evaluation and Research (CDER)

Center for Biologics Evaluation and Research (CBER)

Center for Devices and Radiological Health (CDRH)

Center for Veterinary Medicine (CVM)

Center for Veterinary Medicine (CVM)

U.S Food and drug administration

Page 14: Usfda

14

۩ The FDA consists of employees drawn from a wealth of science and public health professions.

۩ Biologists, physicians, chemists, biomedical engineers, toxicologists, pharmacologists, veterinarians, and specialists in the public health education and communication.

۩ FDA employs approximately 11,516 people who work in locations around the United States.

Who Makes Up the FDA?

Page 15: Usfda

15

How many people are employed by FDA and in what areas do they work?

Center for Biologics Evaluation and Research (CBER) 946Center for Drug Evaluation and Research (CDER) 2,889Center for Devices and Radiological Health (CDRH) 1,203Center for Food Safety and Applied Nutrition (CFSAN) 877Center for Tobacco Products (CTP) 194Center for Veterinary Medicine (CVM) 436National Center for Toxicological Research (NCTR) 217Office of the Commissioner (OC) 859Office of Regulatory Affairs (ORA) 3,895Total 11,516

As of Oct. 1, 2009, FDA employs the following numbers of people in its centers/offices:

Page 16: Usfda

16

۩ They provide FDA with independent advice from outside experts on issues related to human and veterinary drugs, vaccines and other biological products, medical devices, and food.

۩ In general, advisory committees include a chair, several members, plus a consumer, industry, and sometimes a patient representative.

۩ Additional experts with special knowledge may be added for individual committee meetings as needed. although the committees provide advice to the agency, FDA makes the final decisions.

FDA Advisory Committee

Page 17: Usfda

17

۩ People nominated as scientific members must be technically qualified experts in their field, such as,

Clinical medicine

Engineering

Biological and physical sciences

Biostatistics

Food sciences

Qualifications of a scientific member of an advisory committee

Page 18: Usfda

18

۩ They also must have experience interpreting and analyzing detailed scientific data, and understanding its public health significance.

۩ For Example……

۩ people nominated for the Drug Safety and Risk Management Advisory Committee in the Center for Drug Evaluation and Research should be knowledgeable in risk communication, risk management, drug safety, and medical, behavioral, and biological sciences as they apply to risk management and drug abuse.

Page 19: Usfda

19

۩ Foods, except for most meat and poultry products, which are regulated by the U.S. Department of Agriculture. Food additives Infant formulas Dietary supplements Human drugs Vaccines, blood products, and other biologics Medical devices, from simple items like tongue depressors, to complex technologies such as heart pacemakers.

What does FDA regulate?

Page 20: Usfda

20

Electronic products that give off radiation, such as microwave ovens and X-ray equipment.

Cosmetics.

Feed, drugs, and devices used in pets, farm animals, and other animals.

Tobacco products.

Page 21: Usfda

21

۩ FDA does not regulate: advertising (except for prescription drugs, medical devices, and tobacco products). alcoholic beverages some consumer products, such as paint, child- resistant packages, baby toys, and household appliances (except for those that give off radiation) illegal drugs of abuse, such as heroin and marijuana. health insurance. meat and poultry (except for game meats, such as venison, ostrich, and snake). Restaurants and grocery stores.

What doesn’t FDA regulate?

Page 22: Usfda

22

۩ FDA shares the responsibility for regulating these products with other government agencies:

Pesticides (FDA, the U.S. Department of Agriculture, and the Environmental Protection Agency regulate these).

Water (FDA regulates the labeling and safety of bottled water, while the Environmental Protection Agency develops national standards for drinking water from municipal water supplies).

Page 23: Usfda

23

۩ The FDA is the U.S. Government agency that oversees most foods and medical products.۩ Its job is to make sure that: Food is safe, healthy, and clean. Medicines and medical devices are reasonably safe and effective. Cosmetic products are safe. Animal foods and drugs are safe. Food and medical products have proper labels.

Job of the FDA

Page 24: Usfda

24

۩ The programs for safety regulation vary widely by the type of product, its potential risks, and the regulatory powers granted to the agency.

۩ The FDA regulates most products with a set of published standards enforced by a modest number of facility inspections. Inspection observations are documented on Form 483.

Regulatory programs

Page 25: Usfda

25

۩ The Food and Drug Modernization Act states that the FDA has 4 roles:

To promote health by reviewing research and approving new products. To ensure foods and drugs are safe and properly labelled. To work with other nations to “reduce the burden of regulation”. To cooperate with scientific experts and consumers to effectively carry out these obligations.

FDA Mission

Page 26: Usfda

26

Product Approvals (Drugs and Food)۩ The FDA regulates an enormous number of companies. As of November 2000, the FDA's Official Establishment Inventory, the FDA's database of establishments regulated by the agency, included 135,885 firms including these:

64,756 food and cosmetic firms 37,839 device and radiological health firms (of which

roughly 9,500 are mammography facilities) 17,625 human drug firms 7,702 animal drug and feed firms 4,223 biologic firms 2,320 storage warehouses 1,420 miscellaneous food-related facilities

Page 27: Usfda

27

The FDA inspects facilities to ensure compliance with the Food, Drug and Cosmetic Act (FD&C Act) and can seek criminal or civil penalties against both companies and individuals when its regulations are violated.

Intentionally defrauding or misleading the FDA or violating the act may be a felony, but the concept of strict liability means that even those who unintentionally violate the act can be prosecuted for missed manors because intent is not required to violate the law. Missed meaner violations may result in fines of up to $1,000 and up to 1 year in prison.

Enforcement of the FD&C Act

Page 28: Usfda

28

۩ FDA inspects manufacturers or processors of FDA-regulated products to verify that they comply with relevant regulations. ۩Inspected include: vaccine and drug manufacturers blood banks food processing facilities dairy farms animal feed processors

What does FDA inspect?

Page 29: Usfda

29

۩ FDA also inspects.. Facilities that conduct studies in people (clinical trials).

Laboratories that conduct studies in animals or microorganisms when these studies are used to apply for FDA approval of a medical product.

foreign manufacturing and processing sites for FDA- regulated products that are sold in the United States.

Imported products at the border.

Page 30: Usfda

30

۩ FDA conducts several types of inspections to help protect consumers from unsafe products:

pre-approval inspection after a company submits an application to FDA to market a new product.routine inspection of a regulated facility.“for-cause” inspection to investigate a specific problem that has come to FDA’s attention.

۩ FDA makes available to the public certain frequently requested records of inspections in an electronic reading room. You would need to file a Freedom of Information request to obtain other records.

Page 31: Usfda

31

۩ A recall is when a product is removed from the market or a correction is made to the product because it is either defective or potentially harmful. 

۩ Sometimes a company discovers a problem and recalls a product on its own. Other times a company recalls a product after FDA raises concerns.

What is a recall?

Page 32: Usfda

32

۩ Review of FDA inspectional guides

Investigations Operations Manual (IOM) Compliance Program Guidance Manuals(CPGM) Compliance Policy Guides(CPG) Inspection Technical Guides

۩ Review of firm’s Establishment Inspection Report (EIR), Responses to FDA Form 483

etc.

۩ Planning of inspections.

How FDA prepares for Inspections?

Page 33: Usfda

33

۩ FDA Form 482: Notice of inspection.

۩ FDA Form 483: Inspectional observations.

۩ FDA Form 484: Receipt for physical evidence (e.g., samples) , but not for documentary

evidence (e.g., label, copy of records…).

Forms Commonly Used During FDA Inspections

Page 34: Usfda

34

•Developing a comprehensive action plan that optimizes the use of resources to achieve HHS and FDA goals for public Health and safety as well as developing and implementing technology solutions.

•Partnering with programs and industry to provide the innovative information technology that makes it possible to collaborate across government and globally maintaining a secure environment in which security privacy and confidentiality are addressed per U.S.Government laws regulations .

Role of Information Technology in FDA’s mission:

Page 35: Usfda

35

۩ It is FDA program of on-site inspections to ensure the quality and integrity of the data submitted to the agency from regulated clinical trials of investigational

drugs, devices, and biologics.

۩ Inspections are made both in the U.S. and internationally at clinical investigator sites, institutional review boards (IRBs), and sponsors.

۩ (e.g., pharmaceutical, medical device, and biologic companies, including monitors and contract research organizations or CROs working under the sponsor).

Bioresearch Monitoring Program(BIMO)

Page 36: Usfda

36

۩ Inspections are conducted by the following FDA Centres under the BIMO program:

CDRH – FDA Centre for Devices and Radiologic Health. CDER – FDA’s Centre for Drug Evaluation and Research. CBER – Centre for Biologics Evaluation and Research. CVM – FDA’s Centre for Veterinary Medicine. 

Page 37: Usfda

37

۩ Following each BIMO inspection, FDA classifies the overall findings under one of three possible categories:

I. NAI ( No Action Indicated)II. VAI (Voluntary Action Indicated)III.OAI (Official Action Indicated)

Page 38: Usfda

38

۩FDA conducted 1024 total BIMO inspections in 2007, about the same as the prior year’s 1100 inspections. Half of all inspections in 2007 were classified NAI.۩ Of this total number of inspections in 2007:636 were of clinical investigators (52% were NAI, 40% were VAI, 8% were OAI).367 by CDER 183 by CDRH 77 by CBER 9 by CVM

FDA Bioresearch Monitoring (BIMO) Program Activity in 2007

Page 39: Usfda

39

۩221 were of IRBs (51% were NAI, 47% were VAI, 2% were OAI):101 by CDER 92 by CDRH 28 by CBER۩88 were of Sponsors (54% were NAI, 24% were VAI, 22% were OAI):23 by CDER 53 by CDRH [usually higher due to larger number of small device companies doing 1st clinical trial] 12 by CBER

Page 40: Usfda

40

۩ CDRH’s routine inspections focused on paediatric devices and drug-eluting stents in 2007 and, in 2008, on implantable orthopaedic products and cardiovascular devices.

۩ Between 2000 and 2005, FDA inspected only 1% of all clinical trial sites and 75% of the inspections were reviews of already-completed trials for data verification purposes pursuant to a marketing clearance application. Less than 40% of IRBs were inspected during that period.

Page 41: Usfda

41

۩ More recently, FDA has intensified its commitment to this area and the number of inspections will undoubtedly rise. Areas of focus:

Informed Consent – content, timing, documentation. Protocol Compliance – inclusion/exclusion deviations, patient schedule. IRB reporting – notifications for protocol violations, Serious Adverse Events (SAEs), maintenance of ongoing approval. Disclosure and proper documentation of adverse events at the clinical trial site . Drug/Device accountability . Delegation of investigator responsibility to sub-investigators and other staff . Foreign clinical trial sites.

Page 42: Usfda

42

۩ Each FDA Center has oversight of inspections of research related to the product(s) it regulates

۩ Inspections are usually conducted by Office of Regulatory Affairs field investigatorsField inspectors are NOT specifically assigned to CDERAll Field inspectors are responsible for conducting inspections for all centers (CBER, CDER, CDRH, CFSAN, etc.)

BIMO Inspections

Page 43: Usfda

43

0

100

200

300

400

500

600

700

800

FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08

Spon

CI

IRB/RDRC

BIOEQ

GLP

549 556

690723672 667647 674

CDER BIMO Inspections FY 2000-2008

Page 44: Usfda

44

۩ Investigational New Drug Forms (IND) FDA 1571 Investigational New Drug Application FDA 1572  Statement of Investigator Instructions for completing FDA forms 1571 and 1572.

۩ New Drug Application Forms (NDA) Form FDA-356h  Application to Market a New Drug, Biologic, or An Antibiotic Drug For Human Use Form FDA-3397 User Fee Cover Sheet Form FDA-3331 New Drug Application Field Report

Forms and Submission Requirements

Page 45: Usfda

45

Form FDA-356h Application to Market a New Drug, Biologic or An Antibiotic Drug For Human Use.

Guidance for industry: providing regulatory submissions in electronic format –general consideration.

۩ Abbreviated New Drug Application Forms (ANDA) for Generic Drug Products

Page 46: Usfda

46

۩ Orphan Drug Products (for rare diseases and disorders)There is no form, but there is a prescribed format for application for orphan drug status. The section from the regulations that describes the format can be found on this website on the The Orphan Drug Act and Related Law and Regulation page.

۩ Electronic Regulatory Submission & Review (ERSR) Regulation and Instructions For Submitting Drug Application Electronic  This webpage provides for information on CDER's program to enable the electronic submission of regulatory information to the Center and the review of it by CDER staff..

Page 47: Usfda

47

۩ FDA Form Distributions Page. includes links to:

Certification: Financial Interest and Arrangements of Clinical Investigators.

Disclosure: Financial Interest and Arrangements of Clinical Investigators.

MedWatch: FDA Medical Product Reporting Program – Voluntary.

MedWatch: FDA Medical Products Reporting Program – Mandatory.

For electronic form submissions, see Electronic Regulatory Submissions and Review.

Page 48: Usfda

48

۩ There are several ways you can report problems to FDA:

Call the FDA Consumer Complaint Coordinator.Report a Serious Medical Product Problem OnlineReport by Mail: Use postage paid Form FDA 3500Report by FaxReport by Phone Report a vaccine-related illness or injury to the Vaccine

Adverse Event Reporting System (VAERS).

How do problems with an FDA-regulated product are reported?

Page 49: Usfda

49

To report complaints about pet food (and other animal feed), all the FDA Consumer Complaints Coordinator.

Report complaints online related to FDA- regulated Clinical Trials.

Report to FDA’s MedWatch program any product problems or unexpected side effects (adverse events) that occur while using drugs, medical devices, dietary supplements, infant formulas, cosmetics, and blood products and other biologics (except for vaccines) either online, by regular mail, by fax, or by phone.

Page 50: Usfda

50

To find the part of FDA that addresses your area of concern, see Contact FDA.

You may also contact FDA with your comments or questions•by e-mail [email protected]•by mail to Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002•by telephone at 1-888-INFO-FDA (1-888-463-6332), which is the main FDA phone number for general inquiries•by contacting the FDA Public Affairs Specialist for your geographic region

How can we share ideas and suggestions with FDA?

Page 51: Usfda

51

Page 52: Usfda

52

۩ In 2011, (FDA) issued five warning letters to IRBs. None of the five was from an Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited organization.

۩ Since 1996, the FDA has issued 108 warning letters to IRBs.

Summary of FDA warning letters for IRBsPosted by AAHRPP on Monday, January 23,2012

Page 53: Usfda

53

Posted by attilacsordas on February 28, 2009

Page 54: Usfda

54fdaimports.com

Page 55: Usfda

55

In support of the agency's mission to promote and protect the public health, FDA's Strategic Plan focuses on four strategic goals: 55

FDA's Strategic Plan: for the Future

Page 56: Usfda

56

Goal 1: Strengthen FDA for Today and Tomorrow

Goal 2: Improve Patient and Consumer Safety

Goal 3: Increase Access to New Medical and Food Products

Goal 4: Improve the Quality and Safety of Manufactured Products and the Supply Chain